Oruka Therapeutics Inc (ORKA)

Oct 15, 2026

These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead - The Motley Fool

Oct 15, 2026

Oct 14, 2026

Oruka Therapeutics senior vice president Arjun Agarwal sells $805,888 in stock - Investing.com

Oct 14, 2026

Oct 14, 2026

Form 4 Oruka Therapeutics Inc: Arjun Agarwal (Senior Vice President, Finance) For: 12 October - Investing.com India

Oct 14, 2026

Oct 14, 2026

Form 4 Oruka Therapeutics Inc: Arjun Agarwal (Senior Vice President, Finance) For: 12 October - Investing.com UK

Oct 14, 2026

Oct 13, 2026

Oruka Therapeutics' Arjun Agarwal Executes Option Exercises and Sells Nearly 10,000 Shares - Kalkine Media

Oct 13, 2026

Oct 13, 2026

An officer proposes selling 9,999 Oruka Therapeutics (ORKA) shares acquired through stock options. - Stock Titan

Oct 13, 2026

Oct 03, 2026

Form 4 Oruka Therapeutics Inc For: 2 October By Investing.com - Investing.com South Africa

Oct 03, 2026

Oct 02, 2026

Oruka Therapeutics (ORKA) CEO Lawrence Klein Sells 25,000 Shares - GuruFocus

Oct 02, 2026

Oct 02, 2026

Oruka Therapeutics CEO Klein sells $2.09m in stock - Investing.com

Oct 02, 2026

Oct 02, 2026

Form 4 Oruka Therapeutics Inc For: 2 October By Investing.com - Investing.com Nigeria

Oct 02, 2026

Oct 01, 2026

25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). - Stock Titan

Oct 01, 2026

Sep 23, 2026

Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing - GlobeNewswire Inc.

Sep 23, 2026

Sep 22, 2026

Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com Nigeria

Sep 22, 2026

Sep 22, 2026

Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Nigeria

Sep 22, 2026

Sep 22, 2026

Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

Sep 22, 2026

Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com Canada

Sep 22, 2026

Sep 22, 2026

Form 4 Oruka Therapeutics Inc For: 22 September - Investing.com India

Sep 22, 2026

Sep 22, 2026

Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com

Sep 22, 2026

Sep 21, 2026

Details on Warrant Exercise and Subsequent Share Sales by Oruka Therapeutics' General Counsel - Kalkine Media

Sep 21, 2026

Sep 21, 2026

Oruka Therapeutics SVP Arjun Agarwal Sells 533 Shares Under Rule 10b5-1 Plan - Kalkine Media

Sep 21, 2026

Sep 21, 2026

Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock - Investing.com

Sep 21, 2026

Sep 21, 2026

Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com South Africa

Sep 21, 2026

Sep 21, 2026

Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com Nigeria

Sep 21, 2026

Sep 21, 2026

Oruka Therapeutics (NASDAQ: ORKA) insider plans new share sale after recent 10b5-1 trades - Stock Titan

Sep 21, 2026

Sep 16, 2026

Oruka Therapeutics SVP Agarwal sells over $926k in common stock By Investing.com - Investing.com South Africa

Sep 16, 2026

Sep 15, 2026

Oruka Therapeutics SVP Agarwal sells over $926k in common stock - Investing.com India

Sep 15, 2026

Sep 15, 2026

Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock - Investing.com

Sep 15, 2026

Sep 15, 2026

Oruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock - Investing.com

Sep 15, 2026

Sep 15, 2026

Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock By Investing.com - Investing.com Canada

Sep 15, 2026

Sep 15, 2026

Oruka Therapeutics COO Sandler sells $86,713 in common stock - Investing.com

Sep 15, 2026

Sep 15, 2026

Oruka (ORKA) legal chief sells shares to cover RSU taxes - Stock Titan

Sep 15, 2026

Sep 15, 2026

Oruka (ORKA) finance SVP sells 10K shares after option exercises - Stock Titan

Sep 15, 2026

Sep 10, 2026

Oruka Therapeutics to Attend Morgan Stanley Global Healthcare Conference - Bitget

Sep 10, 2026

Sep 09, 2026

Morgan Stanley's New York healthcare conference includes Oruka - Stock Titan

Sep 09, 2026

Sep 09, 2026

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference - GlobeNewswire

Sep 09, 2026

Sep 05, 2026

About Oruka Therapeutics Inc aStock - Coinbase

Sep 05, 2026

Sep 03, 2026

H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy By Investing.com - Investing.com Canada

Sep 03, 2026

Sep 03, 2026

H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy - Investing.com UK

Sep 03, 2026

Sep 02, 2026

UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo

Sep 02, 2026

Sep 02, 2026

Oruka Therapeutics CEO Klein sells $6.8m in stock By Investing.com - Investing.com South Africa

Sep 02, 2026

Sep 02, 2026

Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com South Africa

Sep 02, 2026

Sep 02, 2026

Oruka Therapeutics(ORKA.US) Officer Sells US$6.89 Million in Common Stock - Moomoo

Sep 02, 2026

Sep 01, 2026

Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com Nigeria

Sep 01, 2026

Sep 01, 2026

Oruka Therapeutics CEO Klein sells $6.8m in stock By Investing.com - Investing.com Nigeria

Sep 01, 2026

Sep 01, 2026

Oruka Therapeutics COO Laura Sandler sells $459,101 in stock - Investing.com

Sep 01, 2026

Sep 01, 2026

Oruka Therapeutics CEO Klein sells $6.8m in stock - Investing.com

Sep 01, 2026

Sep 01, 2026

Oruka Therapeutics COO Laura Sandler sells $459,101 in stock - Investing.com India

Sep 01, 2026

Sep 01, 2026

Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com Canada

Sep 01, 2026

Sep 01, 2026

Oruka Therapeutics CEO Klein sells $6.8m in stock - Investing.com UK

Sep 01, 2026

Sep 01, 2026

Insider at Oruka Therapeutics (ORKA) plans stock sale from option exercise - Stock Titan

Sep 01, 2026